Tumor-derived factors such as vascular endothelial growth factor, TGF-β, and prostaglandin E2 recruit myeloid-derived suppressor cells that inhibit the tumoricidal activity of T lymphocytes, facilitating tumor cell survival [8,15]. This evidence concerns the gene VEGFA and neoplasm.